Biolegend, 123140, Alexa Fluor® 594 anti-mouse F4/80 Antibody
100microg
Catalog Number: 123140
Send an RFQ.
Category
| Verified Reactivity | Mouse |
|---|---|
| Antibody Type | Monoclonal |
| Host Species | Rat |
| Immunogen | Murine macrophages |
| Formulation | Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide. |
| Preparation | The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 594 under optimal conditions. |
| Concentration | 0.5 mg/mL |
| Storage & Handling | The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze. |
| Application | IHC-F - Quality tested |
| Recommended Usage | Each lot of this antibody is quality control tested by immunohistochemical staining on frozen tissue sections. For immunohistochemistry, a concentration range of 2.0 - 5.0 μg/mL is suggested. It is recommended that the reagent be titrated for optimal performance for each application. * Alexa Fluor® 594 has an excitation maximum of 590 nm, and a maximum emission of 617 nm. Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.View full statement regarding label licenses |
| Excitation Laser | Green Laser (532 nm)/Yellow-Green Laser (561 nm) |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Application Notes |
|---|
| Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections1,2 and formalin-fixed paraffin-embedded sections6,7, Western blotting, and spatial biology (IBEX)12,13. |
| Application References(PubMed link indicates BioLegend citation) | Schaller E, et al. 2002. Mol. Cell. Biol. 22:8035. (IHC) Stevceva L, et al. 2001. BMC Clin Pathol. 1:3. (IHC) Kobayashi M, et al.2008. J. Leukoc. Biol. 83:1354. PubMed Poeckel D, et al. 2009. J. Biol Chem. 284:21077. PubMed Glass AM, et al. 2013. J. Immunol. 190:4830. PubMed Koehm S, et al. 2007. J. Allergy Clin. Immunol. 120:570. (IHC) Rankin AL, et al. 2010. J. Immunol. 184:1526. (IHC) Sasi SP, et al. 2014. J Biol Chem. 289:14178. PubMed Thakus VS, et al. 2014. Toxicol Lett. 230:322. PubMed Watson NB, et al. 2015. J Immunol. 194:2796. PubMed Hirakawa H, et al. 2015. PLoS One. 10:119360. PubMed Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed |
|---|
| Product Citations | Ferriz M, et al. 2023. STAR Protoc. 4:102079. PubMed Ammassam Veettil R, et al. 2021. Pharmaceutics. 13:. PubMed Grandjean CL, et al. 2021. Sci Adv. 7:. PubMed Liang Y, et al. 2022. Dev Cell. 57:398. PubMed Halin C, et al. 2022. EMBO J. 41:e111528. PubMed Kim JK, et al. 2022. Cell Rep Methods. 2:100353. PubMed Gershater M, et al. 2022. J Immunol. 208:1595. PubMed Orillion A, et al. 2018. Clin Cancer Res. 24:6383. PubMed Merz SF, et al. 2019. Nat Commun. 10:2312. PubMed Xu DQ, et al. 2021. Acta Pharmacol Sin. 42:1080. PubMed Salei N, et al. 2020. J Am Soc Nephrol. 31:257. PubMed Bonnardel J, et al. 2019. Immunity. 51:638. PubMed Peauroi EM, et al. 2022. iScience. 25:105510. PubMed Guilliams M, et al. 2022. Cell. 185:379. PubMed Du J, et al. 2021. Mol Med Rep. 23:. PubMed Fu Y, et al. 2017. Biochem Pharmacol. 10.1016/j.bcp.2017.03.013. PubMed Tu W, et al. 2021. Cell Death Dis. 12:882. PubMed Zhu Q, et al. 2022. Atherosclerosis. 357:41. PubMed Fan ZP, et al. 2021. Front Immunol. 12:743354. PubMed Harding CL, et al. 2020. Front Cell Infect Microbiol. 10:328. PubMed |
|---|
| RRID | AB_2563241 (BioLegend Cat. No. 123140) |
|---|
| Structure | EGF-TM7 family member, 160 kD glycoprotein |
|---|
| Distribution | Majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen, Kupffer cells, Langerhans cells, bone marrow stromal cells, and a subset of dendritic cells |
|---|
| Function | Induction of immunological tolerance |
|---|
| Cell Type | Dendritic cells, Langerhans cells, Macrophages, Tregs |
|---|
| Biology Area | Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience |
|---|
| Antigen References | 1. Austy JM and Gordon S. 1981. Eur. J. Immunol. 11:805. 2. Hume DA, et al. 1983. J. Exp. Med. 158:1522. 3. Ruedl C, et al. 1996. Eur. J. Immunol. 26:1801. 4. McKnight AJ, et al. 1996. J. Biol. Chem. 271:486. 5. Lin HH, et al. 2005. J. Exp. Med. 201:1615. |
|---|
| Gene ID | 13733 |
|---|
| UniProt | View information about F4/80 on UniProt.org |
|---|
| Clone | BM8 |
|---|
| Regulatory Status | RUO |
|---|
| Other Names | EMR1, Ly71 |
|---|
| Isotype | Rat IgG2a, κ |
|---|